ProRx Pharma Redefines Hormone Therapy with Needle-Free Oral Testosterone Option

ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the commercial availability of its oral testosterone, a first-of-its-kind formulation that delivers the ...
Mediafeed on MSN

Ozempic & testosterone: Is there a link?

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Ozempic may help improve testosterone levels in people ...
Contract Pharma

Alteogen, Tesaro Agree to Develop Subcutaneous Form of Dostarlimab

Alteogen and Tesaro, a subsidiary of GSK, have entered an exclusive license agreement concerning a subcutaneous formulation of dostarlimab.
Clinical Advisor

About One-Third of Professionals Prescribe Subcutaneous Contraceptive for Self-Administration

Many professionals report awareness, but few actively prescribe the self-administered injectable contraceptive DMPA.
Fierce Pharma

GSK licenses Alteogen enzyme in bid to develop subQ Jemperli

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women

Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
The New York Times

Testosterone Is Misunderstood

Dr. Sapolsky is a neuroscientist and primatologist. I was observing a 9-year-old male baboon in the Serengeti of East Africa one day in 1983. Baboon troops are very hierarchical, and this baboon was a ...
FiercePharma

With FDA approval, Roche's blood cancer bispecific Lunsumio goes subcutaneous

Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio amid competition among CD20xCD3 bispecific antibodies. The FDA has approved ...
NPR

Testosterone levels have declined in men. Here's what the FDA wants to do about it

A Food and Drug Administration panel of health experts convened Wednesday to discuss and promote the health benefits of testosterone treatments for men. FDA Commissioner Martin Makary told Morning ...
New York Post

FDA panel recommends testosterone therapy be more accessible to men, knocks ‘outdated’ restrictions

This is T-rrific news for some men. Testosterone replacement therapy (TRT) has been historically difficult to get because it requires proof of consistently low testosterone levels along with symptoms ...
MedPage Today

Expand Labeling for Testosterone Replacement Therapy, FDA Panel Says

Members of an FDA expert panel urged the agency to expand labeling for testosterone replacement therapy and remove its classification as a controlled substance. Like previous FDA expert panels, the ...
STAT

In expert panel, FDA says ‘door is open’ for testosterone labeling revisions

Annalisa (Nalis) Merelli is a contributing writer at STAT focused on boys’ and men’s health. Exactly a month after it announced the removal of black box warning labels on estrogen therapy products ...